Sign in

CIK 0001339970

  • Non-accelerated filer
  • Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203435077
Phone
+1 858-731-8389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-05-01 COUGHLIN TIMOTHY Director Grant or award · Stock Option (right to buy) +50,000 50,000
2024-05-30 COUGHLIN TIMOTHY Director Purchase +50,000 $1.75 $88K 56,000
2024-05-22 COUGHLIN TIMOTHY Director Grant or award · Stock Option (right to buy) +24,000 24,000
2023-05-17 COUGHLIN TIMOTHY Director Gift −6,000 0
2023-05-17 COUGHLIN TIMOTHY Director Gift +6,000 6,000
2023-05-17 COUGHLIN TIMOTHY Director Grant or award · Stock Option (right to buy) +12,000 12,000
2023-04-26 COUGHLIN TIMOTHY Director Exercise or conversion +6,000 6,000
2023-04-26 COUGHLIN TIMOTHY Director Exercise or conversion · Restricted Stock Unit −6,000 0
2022-04-26 COUGHLIN TIMOTHY Director Grant or award · Restricted Stock Units +6,000 6,000
2021-04-28 COUGHLIN TIMOTHY Director Grant or award · Stock Option (right to buy) +1,428 1,428
2020-05-06 COUGHLIN TIMOTHY Director Grant or award · Stock Option (right to buy) +1,428 1,428

Page 1 of 1 · 11 trades